MARX Biotech Co (ROCO:7731) NonCurrent Deferred Liabilities: NT$0.0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7731 MARX Biotech Co Ltd ROCO:7731
6 GF Score
Price NT$4.73
! 5 Warning Signs
View Full Analysis

What is MARX Biotech Co NonCurrent Deferred Liabilities?

MARX Biotech Co ROCO:7731 -0.42% 6 NonCurrent Deferred Liabilities is NT$0.0 Mil as of Dec. 2025. GuruFocus rates ROCO:7731 with a GF Score™ of 6/100. The stock has 5 warning signs investors should review.

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

MARX Biotech Co's non-current deferred liabilities for the quarter that ended in Dec. 2025 was NT$0.0 Mil.

MARX Biotech Co NonCurrent Deferred Liabilities Related Terms

MARX Biotech Co NonCurrent Deferred Liabilities Historical Data

* Premium members only.

The historical data trend for MARX Biotech Co's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MARX Biotech Co NonCurrent Deferred Liabilities Chart

MARX Biotech Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Liabilities
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

MARX Biotech Co Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
NonCurrent Deferred Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ROCO:7731
6GF Score
MARX Biotech Co Ltd ROCO:7731
NonCurrent Deferred Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Liabilities of NT$0.0 Mil mean?
MARX Biotech Co (ROCO:7731) has a NonCurrent Deferred Liabilities of NT$0.0 Mil as of Dec. 2025. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on MARX Biotech Co and its competitors.
Is MARX Biotech Co's NonCurrent Deferred Liabilities too high?
MARX Biotech Co's current NonCurrent Deferred Liabilities is NT$0.0 Mil. Overall, MARX Biotech Co has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does MARX Biotech Co's NonCurrent Deferred Liabilities compare to competitors?
MARX Biotech Co's NonCurrent Deferred Liabilities of NT$0.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Liabilities for a Healthcare Providers & Services company?
A good NonCurrent Deferred Liabilities depends on the Healthcare Providers & Services industry context. However, NonCurrent Deferred Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Liabilities mean?
A high NonCurrent Deferred Liabilities can signal that a stock is expensive relative to its fundamentals. Non-current deferred liabilities represent the company obligations not paid yet not due within the current period. View historical data on MARX Biotech Co and its competitors. MARX Biotech Co's current NonCurrent Deferred Liabilities is NT$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MARX Biotech Co stock overvalued right now?
MARX Biotech Co (ROCO:7731) has a current NonCurrent Deferred Liabilities of NT$0.0 Mil. The current NonCurrent Deferred Liabilities is NT$0.0 Mil. MARX Biotech Co's overall GF Score™ is 6/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Liabilities calculated?
NonCurrent Deferred Liabilities is calculated from a company's financial statements. For MARX Biotech Co (ROCO:7731), the current NonCurrent Deferred Liabilities is NT$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

MARX Biotech Co Business Description

Address 5th Floor, No. 655, Bannan Road, Zhonghe district, New Taipei, TWN
MARX Biotech Co Ltd is a retail company which has developed an O2O and OMO full-channel layout in the online Internet platform and cosmeceutical retail market, and has successfully established itself in the market and Build trust and operational growth on the channel side. It has has established more than three thousand large and small cosmeceutical pharmacies in Taiwan, including: Dashu Pharmacy, Dingding Pharmacy, Cosmed, Watsons, Spring Pharmacy, New Gaoqiao Pharmacy, Anlier Pharmacies, etc.
6GF Score

Get the complete analysis for ROCO:7731

NonCurrent Deferred Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$4.73
Price